Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

2754 articles in Drug ShortagesClear all filters
Why Is Ritonavir So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Ritonavir So Hard to Find? [Explained for 2026]

Having trouble finding Ritonavir at your pharmacy? Learn why this HIV medication can be hard to locate, what's causing supply issues, and how to find it in stock near you.

By Peter Daggett·
Blujepa Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Blujepa Shortage Update: What Patients Need to Know in 2026

Is Blujepa in shortage in 2026? Get the latest update on Gepotidacin availability, pricing, and what to do if you can't find it at your pharmacy.

By Peter Daggett·
Envarsus XR Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Envarsus XR Shortage Update: What Patients Need to Know in 2026

Is Envarsus XR in shortage in 2026? Get the latest on availability, pricing, and what transplant patients can do to stay on track.

By Peter Daggett·
Zytiga Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Zytiga Shortage Update: What Patients Need to Know in 2026

Is Zytiga in shortage in 2026? Get the latest update on Zytiga availability, pricing, and what to do if you can't find your prescription filled.

By Peter Daggett·

30,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

Paxlovid Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Paxlovid Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused update on Paxlovid availability in 2026. Covers supply chain status, prescribing considerations, drug interactions, and patient access tools.

By Peter Daggett·
Why Is Prolensa So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Prolensa So Hard to Find? [Explained for 2026]

Prolensa (Bromfenac 0.07%) is hard to find in 2026. Learn why this eye drop is in short supply, what's causing the shortage, and how to find it in stock near you.

By Peter Daggett·
Gloperba shortage update: What patients need to know in 2026
Drug Shortages

Gloperba shortage update: What patients need to know in 2026

Get the latest Gloperba shortage update for 2026. Learn about supply status, what's causing the shortage, and how patients can find it.

By Peter Daggett·
Nadolol Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Nadolol Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on the Nadolol shortage for providers. Learn about supply timelines, prescribing implications, alternatives, and tools to help patients.

By Peter Daggett·
Why Is Ebglyss So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Ebglyss So Hard to Find? [Explained for 2026]

Struggling to find Ebglyss (Lebrikizumab) in 2026? Learn why this atopic dermatitis biologic is hard to find and what you can do to get it.

By Peter Daggett·
Desvenlafaxine XR Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Desvenlafaxine XR Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused briefing on Desvenlafaxine XR availability in 2026, including prescribing implications, alternatives, and patient access tools.

By Peter Daggett·
Methyldopa shortage update: What patients need to know in 2026
Drug Shortages

Methyldopa shortage update: What patients need to know in 2026

Get the latest information on Methyldopa availability in 2026, including current shortage status, pricing updates, and practical solutions for patients.

By Peter Daggett·
Novarel Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Novarel Shortage: What Providers and Prescribers Need to Know in 2026

A provider briefing on the Novarel (hCG) shortage in 2026. Timeline, prescribing implications, availability data, cost considerations, and clinical tools.

By Peter Daggett·
PreviousPage 110 of 230Next